Charles Douglas Blundell
Oprichter bij C4X Discovery Ltd.
Profiel
Charles Douglas Blundell is the founder.
He founded C4X Discovery Ltd.
in 2008 and currently holds the title of Director & Chief Scientific Officer.
He also founded C4X Discovery Holdings Plc in 2008 and held the title of Chief Scientific Officer.
Dr. Blundell obtained a doctorate degree from the University of Oxford.
Actieve functies van Charles Douglas Blundell
| Bedrijven | Functie | Begin |
|---|---|---|
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Oprichter | 23-11-2009 |
Eerdere bekende functies van Charles Douglas Blundell
| Bedrijven | Functie | Einde |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Oprichter | - |
Opleiding van Charles Douglas Blundell
| University of Oxford | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
